Dover, Delaware--(Newsfile Corp. - June 7, 2021) - Encode Ideas, L.P. Initiates Research on Modular Medical, Inc. (OTCQB: MODD). The full research publication can be found on our website at www.encodelp.com.
Encode Ideas, L.P., a healthcare focused research firm, announced today it is initiating coverage on Modular Medical, Inc. (OTCQB: MODD). Modular Medical, Inc. (OTCQB: MODD) is a development-stage diabetes technology company based in San Diego, CA. Modular seeks to expand access to high end diabetes technologies to the heretofore neglected majority of the diabetes market who have been poorly served by the existing options which have been too expensive and complex to drive broad adoption. The strategy is to provide care at a level of cost and complexity designed not for "superusers" but for "the rest of us". Modular Medical was founded by CEO Paul DiPerna, a seasoned medical device professional and world-class microfluidics engineer. Mr. DiPerna was previously the founder (in 2005) of Tandem Diabetes and invented and designed their T:slim insulin pump.
Encode Ideas, L.P. is a healthcare focused research firm, founded in 2019, providing institutional quality research and investment ideas. We undertake an intensive research process to identify healthcare companies that are mispriced or underfollowed. This process lends us towards covering predominately micro / small cap securities, where we feel some of the most intriguing risk reward opportunities exist.
Disclosures
Full disclosures can be found at the end of the report, page 14 and on the website under the disclosure section. The securities of the issuer discussed in this press release may be unsuitable for investors depending on their specific investment objectives and financial position. This research does not constitute a personal trading recommendation or take into account the particular investment objectives, financial situation or needs of an individual reader of this report and does not provide all of the pertinent information to make an investment decision. Neither Encode Ideas, L.P., nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. The information contained herein is based on sources that Encode Ideas, L.P. believes to be reliable but is not guaranteed to be accurate and does not purport to be a complete statement or summary of the available data. Encode Ideas, L.P. has been retained by Modular Medical, Inc. to provide investor awareness and research coverage. This compensation may constitute a conflict of interest as to Encode Ideas L.P.'s ability to remain objective in our communication regarding the profiled company. Readers should always do their own due diligence and consult a financial professional.
Contact
Encode Ideas, L.P.
email: ideas@encodelp.com
twitter: @encodelp
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/86673
